Postpartum depression (PPD) is a common complication of childbearing, and has
increasingly been identified as a major public health problem. Untreated maternal …

This paper resulted from a conference entitled “Lactation and Milk: Defining and refining the
critical questions” held at the University of Colorado School of Medicine from January 18 …

Objective: Postpartum depression (PPD) is a common perinatal complication with adverse
maternal and infant outcomes. This study investigated the efficacy and safety of zuranolone …

Peripartum depression affects up to one in seven women and is associated with significant
maternal and neonatal morbidity if untreated. A history of depression is the strongest risk …

Background: The treatment of breastfeeding mothers with depression raises several
dilemmas, including the possible risk of drug exposure through breast milk for the infant …

We performed an electronic search by using MEDLINE, PreMEDLINE, Current Contents,
Biological Abstracts, and PsycINFO from June 2002 to December 2008 using the following …

The mainstays of treatment for peripartum depression are psychotherapy and
antidepressant medications. More research is needed to understand which treatments are …

Postpartum depression (PPD) is a common, potentially disabling, and, in some cases, life-
threatening condition. Fortunately, PPD is also readily detectable in routine practice and is …

The use of antidepressants in breastfeeding mothers is controversial: Manufacters often
routinely discourage breastfeeding for the nursing mother despite the well-known positive …

This article describes the critical role of neurosteroids in postpartum depression (PPD) and
outlines the landmark pharmacological journey of brexanolone as a first-in-class …